Gene · 3918
Papers2,268
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 2,268
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editorial: Cellular and Molecular Mechanisms at the Proliferation Stage in Wound Healing: From Scarring to Tissue Regeneration. | Front Cell Dev Biol | 2021 | 33681233 | PubTator, text mining | PubMed |
| The Interplay Between Tumor Suppressor p53 and Hypoxia Signaling Pathways in Cancer. | Front Cell Dev Biol | 2021 | 33681231 | PubTator, text mining | PubMed |
| Identification of a Potentially Functional microRNA-mRNA Regulatory Network in Lung Adenocarcinoma Using a Bioinformatics Analysis. | Front Cell Dev Biol | 2021 | 33681226 | PubTator, text mining | PubMed |
| Long Non-Coding RNA Landscape in Prostate Cancer Molecular Subtypes: A Feature Selection Approach. | Int J Mol Sci | 2021 | 33672425 | PubTator, text mining | PubMed |
| New Insights Into Oral Squamous Cell Carcinoma: From Clinical Aspects to Molecular Tumorigenesis. | Int J Mol Sci | 2021 | 33668218 | PubTator, text mining | PubMed |
| Integration of transcriptome analysis with pathophysiological endpoints to evaluate cigarette smoke toxicity in an in vitro human airway tissue model. | Arch Toxicol | 2021 | 33660061 | PubTator, text mining | PubMed |
| Identification of low-frequency variants of UGT1A3 associated with bladder cancer risk by next-generation sequencing. | Oncogene | 2021 | 33658628 | PubTator, text mining | PubMed |
| Gene panel for the diagnosis of epidermolysis bullosa: proposal for a viable and efficient approach. | An Bras Dermatol | 2021 | 33640189 | PubTator, text mining | PubMed |
| Night shift schedule causes circadian dysregulation of DNA repair genes and elevated DNA damage in humans. | J Pineal Res | 2021 | 33638890 | PubTator, text mining | PubMed |
| Associating Multivariate Traits with Genetic Variants Using Collapsing and Kernel Methods with Pedigree- or Population-Based Studies. | Comput Math Methods Med | 2021 | 33628328 | PubTator, text mining | PubMed |
| Noncanonical TGF-β signaling leads to FBXO3-mediated degradation of ΔNp63α promoting breast cancer metastasis and poor clinical prognosis. | PLoS Biol | 2021 | 33626035 | PubTator, text mining | PubMed |
| LAMC2 promotes cancer progression and gemcitabine resistance through modulation of EMT and ATP-binding cassette transporters in pancreatic ductal adenocarcinoma. | Carcinogenesis | 2021 | 33624791 | PubTator, text mining | PubMed |
| Serum Laminin γ2 Monomer as a Diagnostic and Predictive Biomarker for Hepatocellular Carcinoma. | Hepatology | 2021 | 33609304 | PubTator, text mining | PubMed |
| Identification of laminin γ2 as a prognostic and predictive biomarker for determining response to gemcitabine-based therapy in pancreatic ductal adenocarcinoma. | Eur J Cancer | 2021 | 33607476 | PubTator, text mining | PubMed |
| Epigenetic and metabolic regulation of epidermal homeostasis. | Exp Dermatol | 2021 | 33600038 | PubTator, text mining | PubMed |
| Genomic pan-cancer classification using image-based deep learning. | Comput Struct Biotechnol J | 2021 | 33598099 | PubTator, text mining | PubMed |
| Identification of MFGE8 and KLK5/7 as mediators of breast tumorigenesis and resistance to COX-2 inhibition. | Breast Cancer Res | 2021 | 33588911 | PubTator, text mining | PubMed |
| In-Depth Analysis of the Plasma Proteome in ME/CFS Exposes Disrupted Ephrin-Eph and Immune System Signaling. | Proteomes | 2021 | 33572894 | PubTator, text mining | PubMed |
| Current Achievements and Applications of Transcriptomics in Personalized Cancer Medicine. | Int J Mol Sci | 2021 | 33572595 | PubTator, text mining | PubMed |
| Hemozoin Promotes Lung Inflammation via Host Epithelial Activation. | mBio | 2021 | 33563839 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3918/papers?page=45